Westwood Holdings Group’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-47,974
Closed -$933K 492
2024
Q2
$933K Buy
47,974
+22,950
+92% +$601K ﹤0.01% 357
2024
Q1
$939K Buy
+25,024
New +$1.1M 0.01% 362

Other funds holding TXG

Westwood Holdings Group's TXG Position: Q3 2024 in Review

Westwood Holdings Group sold out of 10x Genomics (TXG) in Q3 2024, closing a stake of 47,974 shares — an estimated $933K sold.

Westwood Holdings Group first reported a position in TXG in Q1 2024 and held it in 2 quarters. The position peaked at $939K in Q1 2024. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

  • Westwood Holdings Group reported no remaining 10x Genomics position as of Q3 2024 after selling out during the quarter.
  • Westwood Holdings Group sold 47,974 10x Genomics shares in Q3 2024, an estimated $933K.
  • Westwood Holdings Group first reported a position in 10x Genomics in Q1 2024 and held it in 2 quarters.
  • Westwood Holdings Group's 10x Genomics position peaked at $939K in Q1 2024.
  • 266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on Westwood Holdings Group's 13F filing for Q3 2024, filed 14 Nov 2024.